Zeit | Aktuelle Nachrichten | ||
---|---|---|---|
Fr | Mobilicom Limited (MOB) Secures $1.4M In Orders From Leading Drone Manufacturer | ||
Fr | Here Is What You Need To Know Before Investing In Coda Octopus Group, Inc. (CODA) | ||
Fr | SIFCO Industries, Inc. (SIF) Has Surged 67% Since May. Here Is Why | ||
Fr | CPI Aerostructures, Inc. (CVU) Secures Follow-On Orders Worth $2.4M for Welded Assemblies | ||
Fr | Here Is What You Need To Know Before Investing In Satellogic Inc. (SATL) | ||
Fr | Here Is What You Need To Know Before Investing In Smith & Wesson Brands, Inc. (SWBI) | ||
Fr | Planet Labs PBC (PL) Expands Multi-Year Contract With Instituto Geográfico Agustín Codazzi (IGAC) | ||
Fr | Whirlpool Corporation (WHR): The Dividend Cut Was So Awful, Says Jim Cramer | ||
Fr | Bitcoin fluctuates at high levels, with institutional divestment and favorable policies intertwined - BTC Miner cloud mining platforms become a "safe haven" for stable returns. | ||
Fr | Aristotle Capital's Global Equity Strategy Sold PayPal Holdings (PYPL) for a More Compelling Opportunity | ||
Fr | Here's How Palantir Technologies (PLTR) Impacted Baron Asset Fund's Performance | ||
Fr | Baron Asset Fund's Comments on CoStar Group (CSGP) | ||
Fr | Verisk Analytics (VRSK) Fell Along with Other Defensive Stocks in Q2 | ||
Fr | Here's Why Roper Technologies (ROP) Fell in Q2 | ||
Fr | Why Investors Are Taking a Chance on the Next Big Gaming Trend | ||
Fr | Gartner (IT) Experienced Modest Declined in Q2 Amid Government Spending Cuts | ||
Fr | Delayed AI Software Rollout and Tariff Related Uncertainty Put Pressure on Apple (AAPL) | ||
Fr | Varied Growth Signals Lifted Interactive Brokers Group (IBKR) in Q2 | ||
Fr | Choice Hotels International (CHH) Declined 4.49% in Q2 Due to Investors' Concerns | ||
Fr | 10 Best Stocks to Buy Amid Gold Rally | ||
Fr | Tesla (TSLA) Climbed in Q2 Despite Challenges | ||
Fr | Getty Images Holdings (GETY) - Shutterstock Merger Inches Closer | ||
Fr | Immunitybio (IBRX) Targets $80 Million Capital Raise for Business Operations | ||
Fr | Sana Biotechnology (SANA) Rated 'Market Perform' on Diabetes Program Prospects | ||
Fr | BofA Securities Affirms 'Buy' Rating on Taysha Gene Therapies (TSHA) on TSHA-102 Prospects |